drugset / Trial / NCT00296244
Steroid Free Immunosuppression in Liver Transplantation
RandomizedFactorialOpen-labelTreatment
Summary
The purpose of this study is to determine whether steroid-related complications can be avoided by using steroid-free immuno-suppressive drug regimen after liver transplantation.
Timeline
- Start
- 2006-02
- Primary completion
- 2008-05
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylprednisolone | Other / unclassified | 1000 mg | Intravenous |
| Subject | Prednisone | Other / unclassified | 20 mg | Oral |
| Background | Basiliximab | Monoclonal antibody | 20 mg | Intravenous |
| Background | Tacrolimus | Small molecule | 0.15 mg/kg | Oral |
| Background | mycophenolic acid | Small molecule | 720 mg | Oral |